Average Co-Inventor Count = 2.75
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Numab Therapeutics Ag (10 from 12 patents)
2. Tillotts Pharma Ag (3 from 32 patents)
3. Numab Innovation Ag (3 from 3 patents)
4. Tillotts Pharm Ag (1 from 1 patent)
17 patents:
1. 12209122 - Anti-TNF-alpha-antibodies and functional fragments thereof
2. 12202911 - Multispecific antibody comprising CD137 binding domain and PDL1 binding domain
3. 12098203 - Hetero-dimeric multi-specific antibody format targeting at least CD3 and HSA
4. 12043663 - Anti-TNF-alpha-antibodies and functional fragments thereof
5. 11879005 - Hetero-dimeric multi-specific antibody format
6. 11459383 - Anti-TNF-alpha-antibodies and functional fragments thereof
7. 11427628 - Antibody frameworks
8. 11421035 - Stable antibody variable domain framework combinations and methods of use thereof
9. 11365240 - Anti-HSA antibodies
10. 11319371 - Anti-CD3 antibodies
11. 11236150 - Hetero-dimeric multi-specific antibody format
12. 10975143 - Anti-TNF-α-antibodies and functional fragments thereof
13. 10787508 - Anti-TNFα-antibodies and functional fragments thereof
14. 10774140 - Anti-TNFα-antibodies and functional fragments thereof
15. 10759852 - Anti-TNF-alpha-antibodies and functional fragments thereof